SAN DIEGO, Dec. 1, 2016 /PRNewswire/ -- OncoSec Medical
Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing
DNA-based intratumoral cancer immunotherapies, announced today that
Richard Slansky, OncoSec's Chief
Financial Officer, will be presenting at the 9th annual
LD Micro Main Event on December 7th at 4:00 PM PST at the Luxe Sunset Boulevard Hotel in
Los Angeles, CA.
About LD Micro
LD Micro was founded in 2006 with the
sole purpose of being an independent resource in the microcap
space. The LD Micro Main Event is the largest independent
conference for small/microcap companies and will feature 240
presenting names. For more information, please visit
www.ldmicro.com/events.
About OncoSec Medical Incorporated
OncoSec is a
biotechnology company developing DNA-based intratumoral
immunotherapies with an investigational technology, ImmunoPulse®,
for the treatment of cancer. ImmunoPulse® is designed to
enhance the local delivery and uptake of DNA-based immune-targeting
agents, such as IL-12. In Phase I and II clinical trials,
ImmunoPulse® IL-12 has demonstrated a favorable safety profile and
evidence of anti-tumor activity in the treatment of various solid
tumors as well as the potential to initiate a systemic immune
response. OncoSec's lead program, ImmunoPulse® IL-12, is currently
in clinical development for several indications, including
metastatic melanoma, head and neck cancer, and triple-negative
breast cancer. The program's current focus is on the significant
unmet medical need in patients with melanoma who are refractory or
non-responsive to anti-PD-1/PD-L1 therapies. In addition to
ImmunoPulse® IL-12, the Company is also identifying and developing
new immune-targeting agents for use with the ImmunoPulse® platform.
For more information, please visit www.oncosec.com.
CONTACT:
Sophia Ononye,
PhD MPH MBA
Associate Director, Investor Relations and Corporate
Communications
OncoSec Medical Incorporated
855-662-6732
media@oncosec.com
Logo -
http://photos.prnewswire.com/prnh/20120905/LA68078LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/oncosec-to-present-at-the-9th-annual-ld-micro-main-event-300371114.html
SOURCE OncoSec Medical Incorporated